Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Postmarket Study of Tarvos Microguidewire in Neurovascular Interventional Surgery

NCT: NCT07500155 · COMPLETED

NCT IDNCT07500155
StatusCOMPLETED
Start Date2026-01-29
Completion2026-03-15

Brief Summary

This investigation is to evaluate the clinical effectiveness and safety of the Tarvos Microguidewire in the neurovascular interventional surgery. It is a retrospective multicenter medical device clinical study with real-world data.

Frequently Asked Questions

What is Postmarket Study of Tarvos Microguidewire in Neurovascular Interventional Surgery?

Postmarket Study of Tarvos Microguidewire in Neurovascular Interventional Surgery is a clinical trial registered under NCT07500155. Current status: COMPLETED.

What is the status of NCT07500155?

The current status of NCT07500155 (Postmarket Study of Tarvos Microguidewire in Neurovascular Interventional Surgery) is: COMPLETED.

When did Postmarket Study of Tarvos Microguidewire in Neurovascular Interventional Surgery start?

Postmarket Study of Tarvos Microguidewire in Neurovascular Interventional Surgery started on 2026-01-29.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑